EODData

FRA, PHG: PHARMING GRP SP. ADRS

09 Jan 2026
LAST:

15.40

CHANGE:
 0.70
OPEN:
14.60
HIGH:
15.40
ASK:
0.00
VOLUME:
42
CHG(%):
4.76
PREV:
14.70
LOW:
14.60
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
09 Jan 2614.6015.4014.6015.4042
08 Jan 2614.0014.9014.0014.7042
07 Jan 2613.7014.0013.7014.0042
06 Jan 2613.6014.0013.6013.9042
05 Jan 2613.9014.3013.9014.3042
02 Jan 2614.3014.3013.9013.9042
30 Dec 2513.7013.7013.7013.7042
29 Dec 2514.9015.2013.6015.2042

PROFILE

Name:PHARMING GRP SP. ADRS
About:Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. It has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Sector:Healthcare
Industry:Biotechnology
Address:Darwinweg 24, Leiden, Netherlands, 2333 CR
Website:https://www.pharming.com
ISIN:US71716E1055

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:151.05 
Forward P/E:16.12 
PEG Ratio:-363.33 
Price to Sales:2.23 
Price to Book:2.21 
Profit Margin:-0.02 
Operating Margin:0.03 
Return on Assets:0.03 
Return on Equity:-0.04 
EPS Ratio:0.19 
Revenue:294.94M 
EBITDA:12.47M 
Shares:950.98M 
Market Cap:14.645B 

TECHNICAL INDICATORS

MA5:14.466.5%
MA10:13.6912.5%
MA20:12.3924.3%
MA50:12.1326.9%
MA100:11.0139.9%
MA200:9.6260.0%
STO9:100.00 
STO14:100.00 
RSI14:73.33 
MTM14:4.40
ROC14:0.40 
ATR:0.74 
Week High:15.400.0%
Week Low:13.6013.2%
Month High:15.400.0%
Month Low:10.9060.0%
Year High:15.400.0%
Year Low:5.76167.5%